concept

ASTROCYTE REACTIVITY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ASTROCYTE REACTIVITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

121Connections

6Hypotheses

2Analyses

19Outgoing

50Incoming

0Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	ASTROCYTE REACTIVITY
Key Genes/Proteins	AMYLOID, DRP1, FGFR2, STING
Related Diseases	ALZHEIMER'S DISEASE, ASTROGLIOSIS, INFLAMMATION, MICROGLIAL ACTIVATION, NEUROINFLAMMATION
Related Pathways	CGAS-STING PATHWAY, COMPLEMENT CASCADE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Astrocyte Reactivity Mechanism

mechanism · 4559 words

→

Pathway Diagram

graph TD
    ASTROCYTE_REACTIVITY["ASTROCYTE REACTIVITY"]
    ASTROCYTE_REACTIVITY -->|"contributes to"| Neuroinflammation["Neuroinflammation"]
    ASTROCYTE_REACTIVITY -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
    A1AR["A1AR"] -->|"mediates"| ASTROCYTE_REACTIVITY
    STAT3["STAT3"] -->|"mediates"| ASTROCYTE_REACTIVITY
    CLU["CLU"] -->|"modulates"| ASTROCYTE_REACTIVITY
    DLL4["DLL4"] -->|"upregulates"| ASTROCYTE_REACTIVITY
    ASTROCYTES["ASTROCYTES"] -->|"activates"| ASTROCYTE_REACTIVITY
    SOD1["SOD1"] -->|"activates"| ASTROCYTE_REACTIVITY
    INFLAMMATION["INFLAMMATION"] -->|"contributes to"| ASTROCYTE_REACTIVITY

Outgoing (19)

Target	Relation	Type	Str
Microglial Responses	associated_with	process	0.95
Alzheimer's Disease	contributes_to	disease	0.90
Neuroinflammation	contributes_to	process	0.90
Astrocyte Senescence	associated_with	phenotype	0.85
Central Nervous System Degeneration	associated_with	disease	0.80
Central Nervous System Repair	associated_with	process	0.80
MICROGLIA	interacts_with	cell_type	0.65
TAU	interacts_with	protein	0.65
TAU	causes	protein	0.65
ASTROGLIOSIS	targets	phenotype	0.65
MICROGLIAL ACTIVATION	activates	phenotype	0.65
AMYLOID	causes	protein	0.65
CGAS-STING PATHWAY	regulates	pathway	0.65
ASTROGLIOSIS	causes	phenotype	0.65
CGAS-STING PATHWAY	associated_with	pathway	0.65
TGF-BETA SIGNALING	associated_with	pathway	0.50
COMPLEMENT CASCADE	associated_with	pathway	0.50
CORTEX	associated_with	brain_region	0.45
TEMPORAL LOBE	associated_with	brain_region	0.45

Incoming (102)

Source	Relation	Type	Str
A1AR	mediates	receptor	0.95
Adenosine	associated_with	compound	0.95
STAT3	mediates	protein	0.90
CLU	modulates	protein	0.90
DLL4	upregulates	protein	0.90
White Matter Injury	causes	disease	0.90
ADENOSINE	triggers	compound	0.90
BMAL1	regulates	protein	0.80
Neuroinflammation	associated_with	process	0.80
ASTROCYTES	regulates	cell_type	0.70
IL-6	enhances	gene	0.70
STAT3	activates	protein	0.70
COMPLEMENT CASCADE	inhibits	pathway	0.70
JAK/STAT3 signaling	regulates	pathway	0.70
ASTROCYTE	inhibits	cell_type	0.65
STING	inhibits	gene	0.65
ALZHEIMER'S DISEASE	degrades	disease	0.65
DRP1	activates	gene	0.65
ASTROCYTE	treats	cell_type	0.65
NEUROINFLAMMATION	causes	phenotype	0.65
INFLAMMATION	regulates	phenotype	0.65
FGFR2	exacerbates	gene	0.65
FAS	activates	gene	0.60
APOE	activates	gene	0.60
CLU	regulates	gene	0.60
CLUSTERIN	activates	gene	0.60
TAU	activates	gene	0.60
CXCL1	causes	gene	0.60
CCL5	causes	gene	0.60
NEURODEGENERATION	activates	gene	0.60
NEUROINFLAMMATION	activates	gene	0.60
MITOCHONDRIAL DYSFUNCTION	activates	gene	0.60
ASTROCYTE	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
OXIDATIVE STRESS	activates	gene	0.60
MITOCHONDRIA	activates	gene	0.60
SOD1	activates	gene	0.60
NEURODEGENERATIVE DISEASES	activates	gene	0.60
ACETYL-COA	activates	gene	0.60
MYELIN	activates	gene	0.60
MICROGLIA	activates	gene	0.60
ALZHEIMER'S DISEASE	activates	gene	0.60
TNF	activates	gene	0.60
IL6	activates	gene	0.60
STAT3	activates	gene	0.60
COMPLEMENT	activates	gene	0.60
ALZHEIMER	regulates	gene	0.60
NF-ΚB	activates	gene	0.60
ALZHEIMER'S DISEASE	regulates	gene	0.60
MICROGLIA	regulates	gene	0.60

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vuln	0.690	neurodegeneration	Cell type vulnerability debate in Alzhei
whether the Astrocyte reactivity subtypes in neurodegenerati	0.604	neurodegeneration	Methodology challenge: notebook 'Astrocy
Stratified falsifiers should govern Methodology challenge: n	0.591	neurodegeneration	Methodology challenge: notebook 'Astrocy
Astrocyte reactivity subtypes in neurodegeneration — Rich An	0.577	neurodegeneration	Methodology challenge: notebook 'Astrocy
Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss	0.508	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import

Spinal Cord Astrocyte Reactivity Convergence	0.455	neuroinflammation	Why do clinical manifestations overlap d

Mentioning Analyses (2)

Scientific analyses that reference this entity

Why do clinical manifestations overlap despite distinct underlying etiologies in

neuroinflammation | 2026-04-08 | 7 hypotheses Top: 0.455

Astrocyte reactivity subtypes in neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The abstract notes that clinical presentations overlap across different myelopat

closed · Rounds: 4 · Score: 0.86 · 2026-04-09

What are the mechanisms underlying astrocyte reactivity subtypes in neurodegener

closed · Rounds: 5 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning ASTROCYTE REACTIVITY in their description or question text

Spinal Cord Astrocyte Reactivity Convergence

Score: 0.455 · neuroinflammation · 2026-04-27

Inflammatory myelopathies converge through activation of shared astrocyte reactivity program controlled by JAK/STAT3 sig